Table 33.3—Prescription Medications Commonly Used for Insomnia in Older People
|
Class, Drug |
Starting Dose |
Usual Dose |
Half-Life (hours) |
Comments |
|
Intermediate-acting benzodiazepines |
||||
|
Temazepam |
7.5 mg |
7.5–30 mg |
8.8 |
Psychomotor impairment, increases risk of falls |
|
Short-acting nonbenzodiazepines |
||||
|
Eszopiclone |
1 mg |
1–2 mg |
6 |
Reportedly effective for long-term use in selected individuals; may be associated with unpleasant taste, headache; avoid administration with high-fat meal. |
|
Zaleplon (a pyrazolopyrimidine) |
5 mg |
5–10 mg |
1 (reported unchanged in elderly persons) |
Reportedly little daytime carryover, tolerance, or rebound insomnia |
|
Zolpidem (an imidazopyridine) |
5 mg |
5–10 mg |
1.5–4.5 (3 in elderly persons, 10 in hepatic cirrhosis) |
Reportedly little daytime carryover, tolerance, or rebound insomnia |
|
Sedating antidepressants |
||||
|
MirtazapineOL |
15 mg |
5–45 mg |
31–39 in older adults; 13–34 in younger adults; mean = 21 |
Increased appetite, weight gain, headache, dizziness, daytime carryover; used for insomnia with depression |
|
TrazodoneOL |
25–50 mg |
25–150 mg |
Reportedly 6 ± 2; prolonged in elderly and obese persons |
Moderate orthostatic effects; reportedly effective for insomnia with depression; administration after food minimizes sedation and postural hypotension |